Sunshine Guojian Pharmaceutical(Shanghai) Co.Ltd(688336) : Sunshine Guojian Pharmaceutical(Shanghai) Co.Ltd(688336) : internal control audit report

Internal control audit report of Sunshine Guojian Pharmaceutical(Shanghai) Co.Ltd(688336) Pharmaceutical (Shanghai) Co., Ltd. December 31, 2021

Beijing Institute of Certified Public Accountants

Business report unified coding reporting system

Unified business reporting code: 110 Andon Health Co.Ltd(002432) 022510004069

Name of internal control report of Sunshine Guojian Pharmaceutical(Shanghai) Co.Ltd(688336) Pharmaceutical (Shanghai) Co., Ltd.:

audit

Report No.: Ernst & Young Huaming (2022) ZZ No. 60468439b01

Name of audited (inspected) unit: Sunshine Guojian Pharmaceutical(Shanghai) Co.Ltd(688336) Pharmaceutical (Shanghai) Co., Ltd

Name of accounting firm: Ernst & Young Huaming Certified Public Accountants (special general partnership)

Business type: special audit

Report date: March 28, 2022

Filing date: March 28, 2022

Bao Xiaogang (110 Andon Health Co.Ltd(002432) 550),

Signed by:

Xia Chanyu (31 Shenzhen Zhenye(Group)Co.Ltd(000006) 619)

(information can be queried by scanning QR code or logging into the official website of Beijing injection Association)

Note: this filing information only proves that the report has been filed with the Beijing Institute of certified public accountants, and does not mean that the Beijing Institute of Certified Public Accountants makes any form of guarantee for the content of the report in any sense.

- Advertisment -